S. Fustik (Skopje, North Macedonia), C. Nissenbaum (manchester, United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Trends in cystic fibrosis (CF) survival in South Africa over 40 years
M. Zampoli (Cape Town, South Africa), R. Kassanjee (Cape Town, South Africa), J. Versraete (Cape Town, South Africa), A. Westwood (Cape Town, South Africa), H. Zar (Cape Town, South Africa), B. Morrow (Cape Town, South Africa)
|   |
Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis.
Z. Sadeeva (Moscow, Russian Federation), N. Alyabyeva (Moscow, Russian Federation), I. Novikova (Moscow, Russian Federation), A. Lazareva (Moscow, Russian Federation), Y. Gorinova (Moscow, Russian Federation), O. Simonova (Moscow, Russian Federation)
| |
Feasibility of a virtual multiple breath washout training program
J. Au (Toronto, Canada), C. Saunders (London, United Kingdom), P. Robinson (Sydney, Australia), C. Short (London, United Kingdom), A. Blaxland (Sydney, Australia), R. Seeto (Toronto, Canada), J. Guido (Toronto, Canada), S. Santos (Toronto, Canada), M. Pornillos (Toronto, Canada), R. Jensen (Toronto, Canada), J. Davies (London, United Kingdom), F. Ratjen (Toronto, Canada)
| |
Correlation of the Brody high resolution computed tomography scoring system with aerobic fitness and lung function in patients with cystic fibrosis
N. Campos (Porto Alegre, Brazil), F. Vendrusculo (Porto Alegre, Brazil), I. Almeida (Porto Alegre, Brazil), N. Becker (Porto Alegre, Brazil), L. Pinto (Porto Alegre, Brazil), M. Donadio (Porto Alegre, Brazil)
| |
Immediate effect of huffing on cystic fibrosis respiratory mechanics
T. Castilho (Florianópolis, Brazil), P. Keil (Florianópolis, Brazil), R. Wamosy (Florianópolis, Brazil), J. Cardoso (Florianópolis, Brazil), C. Schivinski (Florianópolis, Brazil)
| |
Recommended shielding against SARS-CoV-2 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis
E. Hatziagorou (Thessaloniki, Greece), I. Toulia (Thessaloniki, Greece), P. Peftoulidou (Thessaloniki, Greece), E. Kouroukli (Thessaloniki, Greece), E. Tasika (Thessaloniki, Greece), E. Chrysochoou (Thessaloniki, Greece), J. Tsanakas (Thessaloniki, Greece)
| |
Targeting Antibiotics to Pseudomonas aeruginosa in Small airways (TAPAS) in patients with Cystic Fibrosis
B. Guidetti (Rotterdam, Netherlands), A. Bos (Rotterdam, Netherlands), E. Van Der Wiel (Rotterdam, Netherlands), I. Meneghelli (Verona, Italy), M. Van Der Eerden (Rotterdam, Netherlands), H. Tiddens (Rotterdam, Netherlands), S. Volpi (Verona, Italy), H. Janssens (Rotterdam, Netherlands)
| |
The effect of COVID-19 pandemic on anxiety levels of children with cystic fibrosis and healthy children
M. Cenk (Istanbul, Turkey), C. Yilmaz Yegit (Istanbul, Turkey), A. Ergenekon (Istanbul, Turkey), A. Toksoy Aksoy (Istanbul, Turkey), G. Bilicen (Istanbul, Turkey), Y. Gokdemir (Istanbul, Turkey), E. Erdem Eralp (Istanbul, Turkey), A. Rodopman Arman (Istanbul, Turkey), F. Karakoc (Istanbul, Turkey), B. Karadag (Istanbul, Turkey)
| |
Evidence for ciliary dyskinesia in cystic fibrosis
R. Bonhiver (Liege, Belgium), N. Bricmont (Liege, Belgium), M. Pirotte (Liege, Belgium), C. Moermans (Liege, Belgium), M. Wuidart (Liege, Belgium), J. Pirson (Liege, Belgium), R. Louis (Liege, Belgium), M. Seghaye (Liege, Belgium), C. Kempeneers (Liege, Belgium), H. Boboli (Liege, Belgium)
| |
Use of portable spirometers in a paediatric cystic fibrosis clinic
K. Newton (SHEFFIELD, United Kingdom)
| |
Lung function in children with cystic fibrosis liver disease
D. Popin (Timisora, Romania), L. Pop (Timisoara, Romania), M. Dediu (Timisoara, Romania), C. Pienar (Timisoara, Romania), L. Savu (Timisoara, Romania), I. Ciuca (Timisoara, Romania)
| |
Impact of Aspergillus fumigatus infection on lung function in children with cystic fibrosis
L. Balanetchi (Chisinau, Republic of Moldova), R. Selevestru (Chisinau, Republic of Moldova), M. Cotorobai (Chisinau, Republic of Moldova), D. Rotaru-Cojocari (Chisinau, Republic of Moldova), C. Tomacinschi (Chisinau, Republic of Moldova), N. Barbova (Chisinau, Republic of Moldova), E. Gudumac (Chisinau, Republic of Moldova), S. Sciuca (Chisinau, Republic of Moldova)
| |
Molecular genetic characteristics of Pseudomonas aeruginosa strains isolated from children with cystic fibrosis in Moscow.
Z. Sadeeva (Moscow, Russian Federation), I. Novikova (Moscow, Russian Federation), N. Alyabyeva (Moscow, Russian Federation), A. Lazareva (Moscow, Russian Federation), Y. Gorinova (Moscow, Russian Federation), O. Simonova (Moscow, Russian Federation)
| |
Late Breaking Abstract - Effects of a new airway clearance technology in children with cystic fibrosis - A homecare randomized controlled trial
K. Walicka-Serzysko (Warsaw, Poland), M. Postek (Warsaw, Poland), J. Milczewska (Warsaw, Poland), N. Jeneralska (Dziekanow Lesny, Poland), A. Cichocka (Dziekanow Lesny, Poland), E. Siedlecka (Dziekanow Lesny, Poland), L. Morin (Montpellier, France), D. Sands (Warsaw, Poland)
| |
Late Breaking Abstract - Lessons from introducing DEKAs as a means of vitamin supplementation in paediatric Cystic Fibrosis patients.
E. Bearblock (Cambridge, United Kingdom), D. Mcshane (Cambridge, United Kingdom), H. Milroy (Cambridge, United Kingdom), S. Aldridge (Cambridge, United Kingdom), D. Kotzia (Cambridge, United Kingdom)
| |
Late Breaking Abstract - Can individualised skin prick tests detect sensitisations against colonising fungal species in cystic fibrosis patients?
S. Zanella (Graz, Austria), V. Strenger (Graz, Austria), W. Buzina (Graz, Austria), S. Kienreich (Graz, Austria), M. Egger (Graz, Austria), A. Pfleger (Graz, Austria), E. Eber (Graz, Austria)
| |
RCT Abstract - The effect of inhaled hypertonic saline on lung structure in preschool children with cystic fibrosis
H. Tiddens (Rotterdam, Netherlands), Y. Chen (Rotterdam, Netherlands), E. Andrinopoulou (Rotterdam, Netherlands), S. Davis (Chapel Hill, United States of America), M. Rosenfeld (Seattle, United States of America), F. Ratjen (Toronto, Canada), R. Kronmal (Seattle, United States of America), K. Stukovsky (Seattle, United States of America), S. Stick (Perth, Australia)
| |